BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23377476)

  • 21. Association of pro-inflammatory cytokines, cortisol and depression in patients with chronic obstructive pulmonary disease.
    Du YJ; Yang CJ; Li B; Wu X; Lv YB; Jin HL; Cao YX; Sun J; Luo QL; Gong WY; Zhang HY; Liu BJ; Wu JF; Dong JC
    Psychoneuroendocrinology; 2014 Aug; 46():141-52. PubMed ID: 24882166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Higher levels of urokinase plasminogen activator system components in the airways of chronic obstructive pulmonary disease patients].
    Xiao W; Tong WL; Ma DD
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Nov; 29(11):723-6. PubMed ID: 17327049
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Local and systemic cellular inflammation and cytokine release in chronic obstructive pulmonary disease.
    Moermans C; Heinen V; Nguyen M; Henket M; Sele J; Manise M; Corhay JL; Louis R
    Cytokine; 2011 Nov; 56(2):298-304. PubMed ID: 21880505
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease.
    Van Pottelberge GR; Mestdagh P; Bracke KR; Thas O; van Durme YM; Joos GF; Vandesompele J; Brusselle GG
    Am J Respir Crit Care Med; 2011 Apr; 183(7):898-906. PubMed ID: 21037022
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease.
    Knobloch J; Sibbing B; Jungck D; Lin Y; Urban K; Stoelben E; Strauch J; Koch A
    J Pharmacol Exp Ther; 2010 Dec; 335(3):788-98. PubMed ID: 20801891
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease.
    Pelegrino NR; Tanni SE; Amaral RA; Angeleli AY; Correa C; Godoy I
    Am J Med Sci; 2013 Jun; 345(6):440-5. PubMed ID: 22874622
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of biomarkers in serum and induced sputum of patients with occupational asthma and chronic obstructive pulmonary disease.
    Kleniewska A; Walusiak-Skorupa J; Piotrowski W; Nowakowska-Świrta E; Wiszniewska M
    J Occup Health; 2016 Jul; 58(4):333-9. PubMed ID: 27265531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of TNF-α, sTNF-R55 and sTNF-R75 in inflammation of acute exacerbations of chronic obstructive pulmonary disease.
    Zeng M; Wen Y; Liu LY; Wang H; Guan KP; Huang X
    Respiration; 2009; 78(4):399-403. PubMed ID: 19339767
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor necrosis factor-{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in chronic obstructive pulmonary disease.
    Sapey E; Wood AM; Ahmad A; Stockley RA
    Am J Respir Crit Care Med; 2010 Jul; 182(2):192-9. PubMed ID: 20299531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease.
    Aaron SD; Angel JB; Lunau M; Wright K; Fex C; Le Saux N; Dales RE
    Am J Respir Crit Care Med; 2001 Feb; 163(2):349-55. PubMed ID: 11179105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smoking affects eotaxin levels in asthma patients.
    Krisiukeniene A; Babusyte A; Stravinskaite K; Lotvall J; Sakalauskas R; Sitkauskiene B
    J Asthma; 2009 Jun; 46(5):470-6. PubMed ID: 19544167
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease.
    Calabrese F; Baraldo S; Bazzan E; Lunardi F; Rea F; Maestrelli P; Turato G; Lokar-Oliani K; Papi A; Zuin R; Sfriso P; Balestro E; Dinarello CA; Saetta M
    Am J Respir Crit Care Med; 2008 Nov; 178(9):894-901. PubMed ID: 18703789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Changes of anaphylatoxin C5a in chronic obstructive pulmonary disease and the relationship with systemic and local inflammation].
    Zhang J; Yao WZ; Sun YC
    Zhonghua Jie He He Hu Xi Za Zhi; 2008 May; 31(5):356-9. PubMed ID: 18953960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. IL-18 in induced sputum and airway hyperresponsiveness in mild asthmatics: effect of smoking.
    Rovina N; Dima E; Gerassimou C; Kollintza A; Gratziou C; Roussos C
    Respir Med; 2009 Dec; 103(12):1919-25. PubMed ID: 19539457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Untargeted lipidomic analysis in chronic obstructive pulmonary disease. Uncovering sphingolipids.
    Telenga ED; Hoffmann RF; Ruben t'Kindt ; Hoonhorst SJ; Willemse BW; van Oosterhout AJ; Heijink IH; van den Berge M; Jorge L; Sandra P; Postma DS; Sandra K; ten Hacken NH
    Am J Respir Crit Care Med; 2014 Jul; 190(2):155-64. PubMed ID: 24871890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of cigarette smoke on the permeability and IL-1beta and sICAM-1 release from cultured human bronchial epithelial cells of never-smokers, smokers, and patients with chronic obstructive pulmonary disease.
    Rusznak C; Mills PR; Devalia JL; Sapsford RJ; Davies RJ; Lozewicz S
    Am J Respir Cell Mol Biol; 2000 Oct; 23(4):530-6. PubMed ID: 11017919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased neutrophil migration in smokers with or without chronic obstructive pulmonary disease.
    Blidberg K; Palmberg L; Dahlén B; Lantz AS; Larsson K
    Respirology; 2012 Jul; 17(5):854-60. PubMed ID: 22509802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Changes of leukotriene B4 in induced sputum and plasma of patients with chronic obstructive pulmonary disease and the effects of theophylline].
    Ding YL; Yao WZ; Liu Z; Wang YZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2005 Jul; 28(7):441-4. PubMed ID: 16115390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of cellular and biochemical markers of airway inflammation in patients with mild-to-moderate asthma and chronic obstructive pulmonary disease: an induced sputum and bronchoalveolar lavage fluid study.
    Gorska K; Krenke R; Domagala-Kulawik J; Korczynski P; Nejman-Gryz P; Kosciuch J; Hildebrand K; Chazan R
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 6():271-83. PubMed ID: 19218651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease.
    Ferhani N; Letuve S; Kozhich A; Thibaudeau O; Grandsaigne M; Maret M; Dombret MC; Sims GP; Kolbeck R; Coyle AJ; Aubier M; Pretolani M
    Am J Respir Crit Care Med; 2010 May; 181(9):917-27. PubMed ID: 20133931
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.